HIGHLIGHTS
- who: Alexa S. Zimbalist from the Division of Research, Kaiser Permanente Northern California, Broadway, Th Floor, Oakland, CA, USA have published the research work: Metabolic abnormalities and survival among patients with non-metastatic breast cancer, in the Journal: (JOURNAL) of December/31,/2019
- what: Only 1 of those studies adjusted for chemotherapy, whereas this study evaluated HDL-C over a long followup period and accounted for the effects of chemotherapy, tamoxifen, aromatase inhibitors, and dyslipidemia medications, all of which affect lipid profiles . Limitations include exclusion of women with insufficient metabolic data; while women in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.